CYP24A1 and colorectal carcinoma: Our study performed differential methylation analysis on promoter CpG sites and included significant CpG sites between CRC tumors and normal tissues in the quantification of CYP24A1 promoter methylation levels, whereas the previous study [33] included all tested promoter CpG sites in their quantification.